David Lopez, 2015 - Google Patents
Biological Studies of Dirhodium (II, II) Compounds and Their Applications as Photochemothreapeutic AgentsDavid Lopez, 2015
View PDF- Document ID
- 5404135801450762693
- Author
- David Lopez A
- Publication year
External Links
Snippet
The work contained in this dissertation focuses on the synthesis and characterization of dirhodium (II, II) compounds and studies of their anticancer activities against cervical and ovarian cancer cell lines. It has been demonstrated that tailoring the coordination …
- 150000001875 compounds 0 title abstract description 353
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/0073—Rhodium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/0046—Ruthenium compounds
- C07F15/0053—Ruthenium compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
- C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/06—Cobalt compounds
- C07F15/065—Cobalt compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/30—Copper compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Knoll et al. | Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy | |
| Li et al. | Phosphorescent iridium (III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents | |
| Fanelli et al. | New trends in platinum and palladium complexes as antineoplastic agents | |
| Mitra et al. | Remarkable anticancer activity of ferrocenyl-terpyridine platinum (II) complexes in visible light with low dark toxicity | |
| Hussain et al. | Enhancing the photocytotoxic potential of curcumin on terpyridyl lanthanide (III) complex formation | |
| Dhar et al. | Ternary copper complexes for photocleavage of DNA by red light: direct evidence for sulfur-to-copper charge transfer and d− d band involvement | |
| Goswami et al. | Photocytotoxicity of copper (II) complexes of curcumin and N-ferrocenylmethyl-L-amino acids | |
| Goswami et al. | Ferrocene-conjugated copper (II) complexes of l-methionine and phenanthroline bases: synthesis, structure, and photocytotoxic activity | |
| Raza et al. | Photoactive platinum (ii) β-diketonates as dual action anticancer agents | |
| Bhattacharyya et al. | BODIPY appended copper (II) complexes of curcumin showing mitochondria targeted remarkable photocytotoxicity in visible light | |
| Kaulage et al. | Novel ruthenium azo-quinoline complexes with enhanced photonuclease activity in human cancer cells | |
| Donzello et al. | Tetra-2, 3-pyrazinoporphyrazines with externally appended pyridine rings. 9. Novel heterobimetallic macrocycles and related hydrosoluble hexacations as potentially active photo/chemotherapeutic anticancer agents | |
| Toubia et al. | Synthesis and anticancer activity of gold porphyrin linked to malonate diamine platinum complexes | |
| Zehra et al. | Water soluble ionic Co (II), Cu (II) and Zn (II) diimine–glycinate complexes targeted to tRNA: Structural description, in vitro comparative binding, cleavage and cytotoxic studies towards chemoresistant prostate cancer cells | |
| Maity et al. | Impact of metal on the DNA photocleavage activity and cytotoxicity of ferrocenyl terpyridine 3d metal complexes | |
| Ramu et al. | Maloplatin-b, a cisplatin-based bodipy-tagged mito-specific “chemo-pdt” agent active in red light | |
| Xue et al. | Photoactivated osmium arene anticancer complexes | |
| Pordel et al. | Release of CO and production of 1O2 from a Mn-BODIPY Photoactivated CO releasing molecule with visible light | |
| Zhou et al. | Rollover cyclometalation vs nitrogen coordination in tetrapyridyl anticancer gold (III) complexes: Effect on protein interaction and toxicity | |
| Kumar et al. | Cellular imaging and mitochondria targeted photo-cytotoxicity in visible light by singlet oxygen using a BODIPY-appended Oxovanadium (IV) DNA crosslinking agent | |
| Binita Chanu et al. | ROS dependent antitumour activity of photo-activated iron (III) complexes of amino acids | |
| Morales et al. | Squaramide-based Pt (II) complexes as potential oxygen-regulated light-triggered photocages | |
| Yousuf et al. | ROS-mediated anticancer response of potent copper (II) drug entities derived from S, O and N, N chelating donor scaffold: Single X-ray crystal diffraction and spectroscopic studies | |
| David Lopez | Biological Studies of Dirhodium (II, II) Compounds and Their Applications as Photochemothreapeutic Agents | |
| Kar et al. | 2-Aryl-1 H-imidazo [4, 5-f][1, 10] phenanthroline-Based Binuclear Ru (II)/Ir (III)/Re (I) Complexes as Mitochondria Targeting Cancer Stem Cell Therapeutic Agents# |